Interestingly, treating primary tumors with neutrophil-derived elastase can attenuate tumor growth at secondary sites in a CD8+ T cell-mediated manner in triple-negative breast cancer and melanoma mice models [82]. This evidence concerns the gene CD8A and neoplasm.